Health In Tech Draws Second $3.0M Yorkville Note at $1.5735 Conversion Price
HIT is trading near its 52-week low of $0.492 (13% above the low) on light trading volume (0.1× avg).
Summary
Health In Tech drew the second $3.0 million tranche of its Yorkville financing, receiving $2.85 million net of a 5% discount. Conversion is set at $1.5735 per share, and total notes now stand at $10.0 million.
Key Events · Financing and Capital Events · HIT
-
Second Yorkville Note Closed
On November 2, 2026, the company issued a second promissory note of $3.0 million principal to YA II PN, Ltd. Purchased at a 5% discount, it delivered $2.85 million in gross proceeds the same day.
-
Total Notes Now $10.0M
Together with the $7.0 million note issued August 18, 2026, the Promissory Notes total $10.0 million principal. They mature February 18, 2028, carry 8.75% interest (18% on default), and include a 4% installment payment premium.
-
Conversion Price Far Above Market
The notes convert at a fixed $1.5735 per share, with a $0.204 floor and a 4.99% ownership blocker. That is roughly 2.8x today's $0.5574 price, so conversion is unlikely without a sharp recovery.
-
Exchange Cap and Shareholder Vote
Issuance is capped at 13,100,378 shares (~19.99% of Class A and Class B outstanding). At the November 10, 2026 annual meeting, the company seeks approval to exceed the cap, alongside a proposal to triple authorized shares to 720 million.
Analysis · HIT · Finance
Health In Tech closed the second pre-paid advance under its Yorkville standby equity agreement, issuing a $3.0 million promissory note for $2.85 million cash after a 5% purchase discount. That brings total notes outstanding to $10.0 million principal. With the conversion price at $1.5735 — far above today's $0.5574 share price — any conversion would be deeply out-of-the-money for the holder unless the stock recovers. Meanwhile, the 8.75% coupon and 4% installment premium are real cash costs for a company that posted a $2.5 million Q2 net loss. The binding constraints are the 13,100,378-share Exchange Cap and the November 10, 2026 shareholder vote on tripling authorized shares to 720 million: without approval, the company cannot issue beyond the cap under Nasdaq rules.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.56 on NASDAQ in the Finance sector, with a market capitalization of approximately $36.4M. The 52-week trading range was $0.49 to $3.05. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.